SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

3 Months Ended

Mar. 31, 2014

Schedule of Segment Reporting Information, by Segment

The following table shows revenue and loss from operations by reportable operating segment for the three months ended March 31, 2014 and 2013 (in thousands):



	Three Months Ended March 31,
	2014			2013
Revenue:
Affymetrix Core	$	59,447		$	55,920
eBioscience	23,524			22,025
Totals	$	82,971		$	77,945
Loss from operations:
Affymetrix Core	$	(7,589	)	$	(8,054	)
eBioscience	(1,153		)	(4,152		)
Totals	$	(8,742	)	$	(12,206	)

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details